AND ORAL CAVITY (ICD‐O C00, C02–06)
Related posts: AND SOFT TISSUE TUMOURS NEUROENDOCRINE TUMOURS OF THE PANCREAS INTESTINE (ICD‐O‐3 ICD‐O C17) TUMOURS FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA (ICD‐O‐3 C56, C57, C48.1, C48.2) (ICD‐O‐3 C60)
Related posts: AND SOFT TISSUE TUMOURS NEUROENDOCRINE TUMOURS OF THE PANCREAS INTESTINE (ICD‐O‐3 ICD‐O C17) TUMOURS FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA (ICD‐O‐3 C56, C57, C48.1, C48.2) (ICD‐O‐3 C60)
COLON AND RECTUM (ICD‐O‐3 C18–20) Rules for Classification The classification applies only to carcinomas. There should be histological confirmation of the disease. Anatomical Sites and Subsites Colon (C18) (Fig. 170)…
PENIS (ICD‐O‐3 C60) Rules for Classification The classification applies only to carcinomas. There should be histological confirmation of the disease. Anatomical Subsites (Fig. 463) Prepuce (C60.0) Glans penis (C60.1) Body…
LARYNX (ICD‐O C32.0, 1, 2, C10.1) Rules for Classification The classification applies only to carcinomas. There should be histological confirmation of the disease. Anatomical Sites and Subsites (Figs. 41, 42,…
Related posts: AND SOFT TISSUE TUMOURS NEUROENDOCRINE TUMOURS OF THE PANCREAS INTESTINE (ICD‐O‐3 ICD‐O C17) TUMOURS FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA (ICD‐O‐3 C56, C57, C48.1, C48.2) URETHRA
CERVIX UTERI (ICD‐O‐3 C53) The definitions of the T and M categories correspond to the FIGO stages. Both systems are included for comparison. Rules for Classification The classification applies only…
PROSTATE (ICD‐O‐3 C61) (FIG. 477, SEE ALSO FIG . 524) Rules for Classification The classification applies only to adenocarcinomas. Transitional cell carcinoma of the prostate is classified as a urethral…
CARCINOMA OF SKIN OF THE HEAD AND NECK (ICD‐O‐3 C44.0, C44.2–4) Rules for Classification The classification applies only to carcinomas, excluding Merkel cell carcinoma. There should be histological confirmation of…
NASAL CAVITY AND PARANASAL SINUSES (ICD‐O C30.0, 31.0, 1) Rules for Classification The classification applies only to carcinomas. There should be histological confirmation of the disease. Anatomical Sites and Subsites…